Jeffrey Epstein &
Boris Nikolic
Biotech venture capitalist, science advisor
Key Facts
Designated alternate/successor executor of the 1953 Trust
Role in Epstein's Will
U.S. Virgin Islands Superior Court Probate Filing (August 2019)
Former chief science adviser to Bill Gates and co-founder of Biomatics Capital
Professional Background
Bloomberg News (August 19, 2019)
Formally refused the appointment and stated he was named entirely without his prior consent
Public Response
The New York Times (August 20, 2019)
More than $577 million
Estate Value at Execution
U.S. Virgin Islands Superior Court Probate Filing (August 2019)

Boris Nikolic · Biotech venture capitalist, science advisor
On August 19, 2019, nine days after Jeffrey Epstein died in his cell at the Metropolitan Correctional Center in Lower Manhattan, probate filings registered in the U.S. Virgin Islands revealed a startling name among the financier's final legal directives. Alongside Epstein's long-serving attorney Darren Indyke and personal accountant Richard Kahn, the will designated Boris Nikolic as an alternate executor of an estate estimated at more than $577 million. The inclusion of Nikolic, a prominent biotechnology venture capitalist and former science adviser to Microsoft co-founder Bill Gates, ignited immediate international scrutiny. Nikolic was not an employee of Epstein's shell corporations, nor had he ever appeared in public legal filings associated with Epstein's previous civil or criminal litigation. His abrupt emergence at the heart of Epstein's post-mortem financial architecture posed urgent questions about how deeply the convicted sex offender had penetrated elite networks of philanthropy, medicine, and venture capital.
Born in Croatia and educated at the University of Zagreb, Nikolic built an accomplished career as an immunologist and medical researcher, holding appointments at Harvard Medical School before transitioning into philanthropic asset management. In 2007, he joined the Bill & Melinda Gates Foundation, eventually serving as the chief science and technology adviser to Gates personally and within bgC3, Gates's private think tank and investment office. In that capacity, Nikolic evaluated groundbreaking medical initiatives, global health projects, and emerging biotechnology firms. After leaving the Gates Foundation orbit in 2014, Nikolic co-founded Biomatics Capital, a venture capital firm focusing on genomics and digital health that raised hundreds of millions of dollars from institutional investors. By all standard measures of Silicon Valley and Boston biotech, Nikolic was an influential, respected gatekeeper for high-risk, high-reward life sciences funding.
Related articles

Jeffrey Epstein and Justin Nelson
Investigative review of Justin Nelson's appearance in Jeffrey Epstein's records, address book entries, and subsequent public document unsealings.
Read article →

Jeffrey Epstein and Mary Erdoes
Investigative review of JPMorgan executive Mary Erdoes, her oversight of Jeffrey Epstein's accounts, and disclosures from the 2023 bank litigation.
Read article →

Jeffrey Epstein and Christian Sewing
Investigative report examining Deutsche Bank CEO Christian Sewing, regulatory oversight, and the institution's relationship with Jeffrey Epstein.
Read article →

Jeffrey Epstein and Paul Hunter
Investigative review of director Paul Hunter's listing in Jeffrey Epstein's address book and the documented facts surrounding their alleged ties.
Read article →